Company intelligence / Profile preview

Epiceutical Labs

Charlottesville, Virginia, United Statesmara-labs.com ↗

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Epiceutical Labs markets BrocElite®, a dietary supplement containing stabilized sulforaphane. The product is claimed to offer clinically relevant doses of this compound with purported benefits in inflammation reduction, brain function protection, detoxification support, and cardiovascular health. No clinical trial data or regulatory drug development stages are reported; products are sold as supplements rather than pharmaceuticals

Therapeutic areas: Metabolic DisordersImmunologyOtherGastroenterologyCardiovascularNeurology
Modalities: Small moleculeNutraceutical
Industry: Food & Nutrition

Drug pipeline

1 asset

BrocElite

Commercial

Indications: Dietary supplement

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on Epiceutical Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epiceutical Labs.

Explore the full profile